Zobrazeno 1 - 10
of 426
pro vyhledávání: '"Mario, Roselli"'
Autor:
Roberto Rosenfeld, Silvia Riondino, Giusy Parisi, Giovanni Maria Iannantuono, Rexhina Ajdhoni, Francesco Torino, Sabrina Mariotti, Mario Roselli
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
The treatment of patients affected by a teratoma with somatic-type malignancy (STM) is challenging, since they are characterized by a poor prognosis, due to chemoresistance to standard cisplatin-based regimens. Only five more case reports were descri
Externí odkaz:
https://doaj.org/article/c022e843be7d4d029affeaee9f25268a
Autor:
Massimiliano Berretta, Daniele Garozzo, Calogero Foti, Mario Roselli, Marco Materazzo, Giulia Vita, Ferdinando Iellamo, Marco Scordari, Giordana Di Mauro, Giovanna Spatari, Alessandro Ottaiano, Annalisa Noce, Marco Pellicciaro, Alessia Bignucolo, Gianluca Vanni, Oreste Claudio Buonomo
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundImproving prognosis of BC patients has drawn the attention of health care professionals on disease related long-term side effects and on the multiple treatments BC patients must undergo. Despite advances in procedures, surgery still has mul
Externí odkaz:
https://doaj.org/article/0d588f8074c34f37ba8f7e780e2da356
Autor:
Maria Cristina Rapanotti, Tonia Cenci, Maria Giovanna Scioli, Elisa Cugini, Silvia Anzillotti, Luca Savino, Deborah Coletta, Cosimo Di Raimondo, Elena Campione, Mario Roselli, Sergio Bernardini, Luca Bianchi, Anastasia De Luca, Amedeo Ferlosio, Augusto Orlandi
Publikováno v:
Biomedicines, Vol 12, Iss 9, p 2137 (2024)
Circulating tumor cells (CTCs) currently represent a revolutionary tool offering unique insights for the evaluation of cancer progression, metastasis, and response to therapies. Indeed, CTCs, upon detachment from primary tumors, enter the bloodstream
Externí odkaz:
https://doaj.org/article/faa2bfd5768745df992b5087390b4482
Autor:
Giovanni Maria Iannantuono, Dara Bracken-Clarke, Charalampos S. Floudas, Mario Roselli, James L. Gulley, Fatima Karzai
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
The development of large language models (LLMs) is a recent success in the field of generative artificial intelligence (AI). They are computer models able to perform a wide range of natural language processing tasks, including content generation, que
Externí odkaz:
https://doaj.org/article/6a3c519940f54eab87d348289a43f5e8
Autor:
Silvia Riondino, Vincenzo Formica, Elena Valenzi, Cristina Morelli, Valeria Flaminio, Ilaria Portarena, Francesco Torino, Mario Roselli
Publikováno v:
Current Oncology, Vol 30, Iss 1, Pp 1220-1231 (2023)
Background: Aromatase inhibitors (AI) are widely used for treating hormone-sensitive breast cancer (BC). Obesity, however, due to aromatase-mediated androgen conversion into estradiol in the peripheral adipose tissue, might impair AI inhibitory capac
Externí odkaz:
https://doaj.org/article/710140592e9c4a799d00a6c215e557d7
Autor:
Andrea M. Guida, Bruno Sensi, Vincenzo Formica, Rolando M. D’Angelillo, Mario Roselli, Giovanna Del Vecchio Blanco, Piero Rossi, Gabriella T. Capolupo, Marco Caricato, Giuseppe S. Sica
Publikováno v:
Biology Direct, Vol 17, Iss 1, Pp 1-14 (2022)
Abstract Colorectal carcinoma is the second leading cause of cancer-related deaths, and indeed, rectal cancer accounting for approximately one third of newly diagnosed patients. Gold standard in the treatment of rectal cancer is a multimodality appro
Externí odkaz:
https://doaj.org/article/d99fdf96c95f4934b155bd49f8080263
Autor:
Carlo Ganini, Ivano Amelio, Riccardo Bertolo, Pierluigi Bove, Oreste Claudio Buonomo, Eleonora Candi, Chiara Cipriani, Nicola Di Daniele, Hartmut Juhl, Alessandro Mauriello, Carla Marani, John Marshall, Sonia Melino, Paolo Marchetti, Manuela Montanaro, Maria Emanuela Natale, Flavia Novelli, Giampiero Palmieri, Mauro Piacentini, Erino Angelo Rendina, Mario Roselli, Giuseppe Sica, Manfredi Tesauro, Valentina Rovella, Giuseppe Tisone, Yufang Shi, Ying Wang, Gerry Melino
Publikováno v:
Molecular Oncology, Vol 15, Iss 11, Pp 2823-2840 (2021)
Cancer genomes have been explored from the early 2000s through massive exome sequencing efforts, leading to the publication of The Cancer Genome Atlas in 2013. Sequencing techniques have been developed alongside this project and have allowed scientis
Externí odkaz:
https://doaj.org/article/c650bf47946544368cb8e24b3e99c3bf
Autor:
Laura Pizzuti, Maddalena Barba, Marco Mazzotta, Eriseld Krasniqi, Marcello Maugeri-Saccà, Teresa Gamucci, Rossana Berardi, Lorenzo Livi, Corrado Ficorella, Clara Natoli, Enrico Cortesi, Daniele Generali, Nicla La Verde, Alessandra Cassano, Emilio Bria, Luca Moscetti, Andrea Michelotti, Vincenzo Adamo, Claudio Zamagni, Giuseppe Tonini, Domenico Sergi, Daniele Marinelli, Giancarlo Paoletti, Silverio Tomao, Andrea Botticelli, Paolo Marchetti, Nicola Tinari, Antonino Grassadonia, Maria Rosaria Valerio, Rosanna Mirabelli, Maria Agnese Fabbri, Nicola D’Ostilio, Enzo Veltri, Domenico Corsi, Ornella Garrone, Ida Paris, Giuseppina Sarobba, Icro Meattini, Mirco Pistelli, Francesco Giotta, Vito Lorusso, Carlo Garufi, Antonio Russo, Marina Cazzaniga, Pietro Del Medico, Mario Roselli, Angela Vaccaro, Letizia Perracchio, Anna di Benedetto, Theodora Daralioti, Isabella Sperduti, Ruggero De Maria, Angelo Di Leo, Giuseppe Sanguineti, Gennaro Ciliberto, Patrizia Vici
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract In metastatic breast cancer (mBC), the change of human epidermal growth factor receptor 2 (HER2) status between primary and metastatic lesions is widely recognized, however clinical implications are unknown. Our study address the question if
Externí odkaz:
https://doaj.org/article/480280eb7ab4458fa7a0a13c1dcceb2c
Autor:
Giulia Bon, Laura Pizzuti, Valentina Laquintana, Rossella Loria, Manuela Porru, Caterina Marchiò, Eriseld Krasniqi, Maddalena Barba, Marcello Maugeri-Saccà, Teresa Gamucci, Rossana Berardi, Lorenzo Livi, Corrado Ficorella, Clara Natoli, Enrico Cortesi, Daniele Generali, Nicla La Verde, Alessandra Cassano, Emilio Bria, Luca Moscetti, Andrea Michelotti, Vincenzo Adamo, Claudio Zamagni, Giuseppe Tonini, Giacomo Barchiesi, Marco Mazzotta, Daniele Marinelli, Silverio Tomao, Paolo Marchetti, Maria Rosaria Valerio, Rosanna Mirabelli, Antonio Russo, Maria Agnese Fabbri, Nicola D’Ostilio, Enzo Veltri, Domenico Corsi, Ornella Garrone, Ida Paris, Giuseppina Sarobba, Francesco Giotta, Carlo Garufi, Marina Cazzaniga, Pietro Del Medico, Mario Roselli, Giuseppe Sanguineti, Isabella Sperduti, Anna Sapino, Ruggero De Maria, Carlo Leonetti, Angelo Di Leo, Gennaro Ciliberto, Rita Falcioni, Patrizia Vici
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 39, Iss 1, Pp 1-14 (2020)
Abstract Background HER2-targeting agents have dramatically changed the therapeutic landscape of HER2+ advanced breast cancer (ABC). Within a short time frame, the rapid introduction of new therapeutics has led to the approval of pertuzumab combined
Externí odkaz:
https://doaj.org/article/4d34ed52da98405db47bb21f0f6da119
Autor:
Cremolini, Vincenzo Formica, Cristina Morelli, Veronica Conca, Maria Alessandra Calegari, Jessica Lucchetti, Emanuela Dell’Aquila, Marta Schirripa, Marco Messina, Lisa Salvatore, Federica Lo Prinzi, Giovanni Dima, Giovanni Trovato, Silvia Riondino, Mario Roselli, Ferdinandos Skoulidis, Hendrik-Tobias Arkenau, Chiara
Publikováno v:
Cancers; Volume 15; Issue 11; Pages: 3064
Background: KRASG12C-mutated metastatic colorectal cancer (mCRC) has recently been recognized as a distinct druggable molecular entity; however, there are limited data on its sensitivity to standard chemotherapy. In the near future, the combination o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::a73de92a74132bdbbd1cb71afba30b68